SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-21-126914
Filing Date
2021-10-18
Accepted
2021-10-18 06:01:23
Documents
4
Period of Report
2021-11-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2129502-2_def14a.htm DEF 14A 491647
2 GRAPHIC lg_regenerx-4c.jpg GRAPHIC 53290
3 GRAPHIC tm2129502d2-px_01proxybw.jpg GRAPHIC 355038
4 GRAPHIC tm2129502d2-px_02proxy4c.jpg GRAPHIC 284632
  Complete submission text file 0001104659-21-126914.txt   1391412
Mailing Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850 301-208-9191
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-15070 | Film No.: 211327227
SIC: 2834 Pharmaceutical Preparations